Bevacizumab or cetuximab plus chemotherapy after progression with bevacizumab plus chemotherapy in patients with wtKRAS metastatic colorectal cancer: A randomized phase II study (Prodige 18-UNICANCER GI).

Affiliation auteurs!!!! Error affiliation !!!!
TitreBevacizumab or cetuximab plus chemotherapy after progression with bevacizumab plus chemotherapy in patients with wtKRAS metastatic colorectal cancer: A randomized phase II study (Prodige 18-UNICANCER GI).
Type de publicationJournal Article
Year of Publication2016
AuteursHiret S, Borg C, Bertaut A, Bouche O, Adenis A, Deplanque G, Francois E, Conroy T, Ghiringhelli F, Guetz GDes, Seitz J-F, Artru P, Stanbury T, Denis MG, Bennouna J
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume34
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2016.34.15_suppl.3514